Free Trial

ClearPoint Neuro Q4 2022 Earnings Report

ClearPoint Neuro logo
$16.72 -0.73 (-4.18%)
As of 02/21/2025 04:00 PM Eastern

ClearPoint Neuro EPS Results

Actual EPS
-$0.18
Consensus EPS
-$0.22
Beat/Miss
Beat by +$0.04
One Year Ago EPS
N/A

ClearPoint Neuro Revenue Results

Actual Revenue
$5.17 million
Expected Revenue
$5.19 million
Beat/Miss
Missed by -$20.00 thousand
YoY Revenue Growth
N/A

ClearPoint Neuro Announcement Details

Quarter
Q4 2022
Time
N/A

CLPT Upcoming Earnings

ClearPoint Neuro will be holding an earnings conference call on Wednesday, February 26 at 4:30 PM Eastern. Interested parties can register for or listen to the call or dial in at 201-612-7415 using passcode "413671".

Conference Call Resources

Conference Call Audio

ClearPoint Neuro Earnings Headlines

ClearPoint Neuro (CLPT) to Release Earnings on Wednesday
Collect $7k per month from Tesla’s SECRET dividend
There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?
Solventum (NYSE:SOLV) vs. ClearPoint Neuro (NASDAQ:CLPT) Critical Analysis
See More ClearPoint Neuro Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like ClearPoint Neuro? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ClearPoint Neuro and other key companies, straight to your email.

About ClearPoint Neuro

ClearPoint Neuro (NASDAQ:CLPT) operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

View ClearPoint Neuro Profile

More Earnings Resources from MarketBeat